An assay is available to determine the presence or absence of oestrogen receptors in breast cancer cells. The presence of oestrogen receptors predicts a 60% response rate to empirical hormonal therapy, and the absence a 10% response rate. Early evidence suggests that the additional presence of other hormone receptors in breast cancer cells will improve this response rate.
View Article and Find Full Text PDF